Fennec Pharmaceuticals Inc. ( FENC) - Stock Earnings
FENC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
FENC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -4.8 million USD | 13.8 million USD |
| 2026Q1 | 201000 USD | 15.1 million USD |
| 2026Q2 | 2.0 million USD | 17.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
FENC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -16.0 million USD | 21.3 million USD |
| 2024 | -436000 USD | 47.5 million USD |
| 2025 | -9.7 million USD | 44.6 million USD |
| 2026 Est. | — | — |
FENC
Price: $9.98
52 week price:
Earnings Per Share: -0.12 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 138134
Ebitda: -2.2 millionMarket Capitalization: 354.3 million